课题基金 / 基金详情

项目摘要

项目成果

MATTHEW A MULVEY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The urinary tract is normally a sterile environment, kept free of microbes by the flow of urine and by myriad anti-microbial molecules and effector immune cells. However, despite these formidable host defenses and the increasing usage of antibiotics, urinary tract infections (UTIs) remain among the most common of infectious diseases worldwide. Strains of uropathogenic Escherichia coli (UPEC), which are the principal cause of UTIs, are able to invade host bladder epithelial cells and subsequently multiply, forming large intracellular inclusions that resemble biofilms. Alternately, intracellular UPEC can persist at low levels in a more quiescent, non-replicating state that may serve as a reservoir for future recurrent acute infections. Invasion of host cells and tissues within the urinary tract promotes the persistence of UPEC in the face of both innate and adaptive host responses, as well as many antibiotic treatments. The primary objectives of this proposal are to define the host and bacterial factors that mediate UPEC invasion, intracellular growth, and persistence within the bladder epithelium. Biochemical, pharmacological, genetic, and microscopic approaches coupled with in vivo model systems will be employed. It is hoped that the proposed work will provide a more complete understanding of the pathogenesis of both acute and recurrent UTIs and ultimately facilitate the development of improved therapeutics for treating and preventing these exceptionally common infections. PUBLIC HEALTH RELEVANCE: Urinary tract infections are among the most common of infectious diseases, representing a serious economic and medical burden worldwide. By delineating how uropathogenic bacteria colonize and persist within the host, we hope to facilitate the development of improved therapeutics.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.chom.2011.12.003
发表时间: 2012-01-19
期刊: Cell host & microbe
影响因子: 30.3
作者: [Dhakal BK, Mulvey MA]
通讯作者: Mulvey MA
Impact of Flagellin Variants and Receptors on the Progression and Outcome of Sepsis
  • 批准号:
    9811363
  • 项目类别:
  • 资助金额:
    $38.13万
  • 财政年份:
    2019
  • 负责人:
    MATTHEW A MULVEY
  • 依托单位:
Impact of Flagellin Variants and Receptors on the Progression and Outcome of Sepsis
  • 批准号:
    9983099
  • 项目类别:
  • 资助金额:
    $38.13万
  • 财政年份:
    2019
  • 负责人:
    MATTHEW A MULVEY
  • 依托单位:
Impact of Flagellin Variants and Receptors on the Progression and Outcome of Sepsis
  • 批准号:
    10387952
  • 项目类别:
  • 资助金额:
    $8.87万
  • 财政年份:
    2019
  • 负责人:
    MATTHEW A MULVEY
  • 依托单位:
Impact of Flagellin Variants and Receptors on the Progression and Outcome of Sepsis
  • 批准号:
    10386796
  • 项目类别:
  • 资助金额:
    $38.13万
  • 财政年份:
    2019
  • 负责人:
    MATTHEW A MULVEY
  • 依托单位:
海外基金